TSX Delisting Review – Acerus Pharmaceuticals Corporation (ASP)

February 6, 2023
Issuer: Acerus Pharmaceuticals Corporation
Securities: Common Shares (the "Securities")
Symbol(s): ASP
Delisting Date: March 3, 2023 (at the close)
Reason: Failure to meet continued listing requirements.
Trading Status: The Securities will remain suspended from trading.
Additional Information: TSX Bulletin 2023-0057 dated January 26, 2023.
TSX contact: Selma Thaver,
TSX Listings